TY - JOUR
T1 - Update on the Diagnostic Pitfalls of Autopsy and Post-Mortem Genetic Testing in Cardiomyopathies
AU - Grassi, Simone
AU - Campuzano, Oscar
AU - Coll, Mònica
AU - Cazzato, Francesca
AU - Sarquella-Brugada, Georgia
AU - Rossi, Riccardo
AU - Arena, Vincenzo
AU - Brugada, Josep
AU - Brugada, Ramon
AU - Oliva, Antonio
PY - 2021
Y1 - 2021
N2 - Inherited cardiomyopathies are frequent causes of sudden cardiac death (SCD), especially in young patients. Despite at the autopsy they usually have distinctive microscopic and/or macroscopic diagnostic features, their phenotypes may be mild or ambiguous, possibly leading to misdiagnoses or missed diagnoses. In this review, the main differential diagnoses of hypertrophic cardiomyopathy (e.g., athlete’s heart, idiopathic left ventricular hypertrophy), arrhythmogenic cardiomyopathy (e.g., adipositas cordis, myocarditis) and dilated cardiomyopathy (e.g., acquired forms of dilated cardiomyopathy, left ventricular noncompaction) are discussed. Moreover, the diagnostic issues in SCD victims affected by phenotype-negative hypertrophic cardiomyopathy and the relationship between myocardial bridging and hypertrophic cardiomyopathy are analyzed. Finally, the applications/limits of virtopsy and post-mortem genetic testing in this field are discussed, with particular attention to the issues related to the assessment of the significance of the genetic variants.
AB - Inherited cardiomyopathies are frequent causes of sudden cardiac death (SCD), especially in young patients. Despite at the autopsy they usually have distinctive microscopic and/or macroscopic diagnostic features, their phenotypes may be mild or ambiguous, possibly leading to misdiagnoses or missed diagnoses. In this review, the main differential diagnoses of hypertrophic cardiomyopathy (e.g., athlete’s heart, idiopathic left ventricular hypertrophy), arrhythmogenic cardiomyopathy (e.g., adipositas cordis, myocarditis) and dilated cardiomyopathy (e.g., acquired forms of dilated cardiomyopathy, left ventricular noncompaction) are discussed. Moreover, the diagnostic issues in SCD victims affected by phenotype-negative hypertrophic cardiomyopathy and the relationship between myocardial bridging and hypertrophic cardiomyopathy are analyzed. Finally, the applications/limits of virtopsy and post-mortem genetic testing in this field are discussed, with particular attention to the issues related to the assessment of the significance of the genetic variants.
KW - cardiomyopathies
KW - forensic autopsy
KW - post-mortem genetic testing
KW - sudden cardiac death
KW - virtopsy
KW - cardiomyopathies
KW - forensic autopsy
KW - post-mortem genetic testing
KW - sudden cardiac death
KW - virtopsy
UR - http://hdl.handle.net/10807/177444
U2 - 10.3390/ijms22084124
DO - 10.3390/ijms22084124
M3 - Article
SN - 1422-0067
VL - 22
SP - 4124
EP - 4143
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
ER -